Jim has over 25 years of experience in the healthcare industry, investment banking, and public accounting. Prior to joining Craig-Hallum he was the CFO of Miromatrix Medical (NASDAQ: MIRO), where he played a pivotal role in the company’s sale to United Therapeutics (NASDAQ: UTHR). From 2005 to 2022, Jim was a Managing Director at Piper Sandler in the Healthcare Investment Banking group advising medical device and biotechnology companies in M&A and financing transactions. From 2001 to 2005, Jim worked at Abbott Laboratories in the Corporate FP&A division and Global Pharmaceutical Operations division (now AbbVie).  Jim began his career as an auditor and CPA (inactive) at PricewaterhouseCoopers. He holds a B.A. in Accounting from the University of Wisconsin–Milwaukee and an MBA from Northwestern University’s Kellogg School of Management.